Skip to main content
HCONRES 314 108th Congress House Health Access to health care Blood diseases Child health Congress Congressional reporting requirements Genetic counseling Health education Hemophilia Hormones Hysterectomy Medical research Medical screening Medical tests Menstruation Preventive medicine Science, Technology, Communications Women's health

Expressing the sense of Congress regarding women with bleeding disorders.

Introduced: October 29, 2003 See on congress.gov
This resolution expired with the 108th Congress
It was not agreed to before the 108th Congress (2003–2004) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Nov 14, 2003
Referred to the Subcommittee on Health.
Oct 29, 2003
Referred to the House Committee on Energy and Commerce.
Oct 29, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Expresses the sense of Congress that: (1) the Federal Government has a responsibility to further research on von Willebrand's disease, improve access to treatment centers for all individuals with bleeding disorders, and increase funding for research; (2) the Director of the National Institutes of Health should develop a 5-year research plan concerning women with bleeding disorders; (3) the Director of the Centers for Disease Control and Prevention should continue to improve outreach, treatment, and prevention of the complications of women's bleeding disorders; (4) physicians should screen all adolescents and all adult women presenting with severe menorrhagia for von Willebrand's disease; (5) hysterectomy for excessive menstrual bleeding should not be performed without the consideration of a bleeding disorder; (6) referral of women with bleeding disorders to a federally sponsored hemophilia treatment center is critical to comprehensive treatment; (7) physicians should be encouraged to conduct clotting factor assays for carrier diagnosis and to facilitate genotyping of the disorder and patients should be referred for genetic counseling when appropriate; and (8) patient advocate organizations and medical specialty societies should continue to collaborate on public education campaigns to educate women about bleeding disorders.
What's happening now November 14, 2003

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 314: Expressing the sense of Congress regarding women with bleeding disorders.. 108th Congress. Open America. https://openamerica.io/bill/108-HCONRES-314/
MLA
"H. Con. Res. 314: Expressing the sense of Congress regarding women with bleeding disorders.." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HCONRES-314/.
Bluebook (legal)
H. Con. Res. 314, 108th Cong. (2026), https://openamerica.io/bill/108-HCONRES-314/.
Markdown link
[H. Con. Res. 314: Expressing the sense of Congress regarding women with bleeding disorders.](https://openamerica.io/bill/108-HCONRES-314/)
Report a problem